Company-wide revenue
Reported revenue in 2021 ¥375.72B Reported revenue in 2025 ¥421.56B
- growth amount
- +¥45.84B
- growth annualized
- +2.9%
- growth total
- +12.2%
Japanese company profile · 3101
TOYOBO CO.,LTD.
In its FY2025 public filing, TOYOBO CO.,LTD. reports Life Sciences, Real Estate. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 東洋紡株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
TOYOBO CO.,LTD.'s largest reported business by revenue in FY2025 was Life Sciences.
The business with the highest reported segment profit in FY2025 was Real Estate.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Life Sciences | ¥34.68B ↗ | 8.2% | ¥65M ↗ |
| Real Estate | ¥5.66B ↗ | 1.3% | ¥2.05B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Life Sciences
- ライフサイエンス
- Real Estate
- 不動産
- Business label unavailable in English
- フィルム・機能マテリアル
- Mobility
- モビリティ
- Business label unavailable in English
- 生活・環境
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Life Sciences
- ライフサイエンス
- Real Estate
- 不動産
- Business label unavailable in English
- フィルム・機能マテリアル
- Mobility
- モビリティ
- Business label unavailable in English
- 生活・環境
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Real Estate
Reported revenue in 2021 ¥4.38B Reported revenue in 2025 ¥5.66B
- growth amount
- +¥1.28B
- growth annualized
- +6.6%
- growth total
- +29.3%
View original filing
Real Estate
Reported profit margin in 2022 +32.1%
Reported profit margin in 2025 +36.2%
- growth margin points
- +4.1
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YGRC
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.